| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cancer statistics, 2012.
|
CA Cancer J Clin
|
2012
|
87.38
|
|
2
|
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
|
Eur J Cancer
|
2009
|
77.71
|
|
3
|
Optimal two-stage designs for phase II clinical trials.
|
Control Clin Trials
|
1989
|
21.03
|
|
4
|
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.
|
N Engl J Med
|
2002
|
10.80
|
|
5
|
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
|
N Engl J Med
|
2007
|
10.06
|
|
6
|
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.
|
Eur J Cancer
|
1999
|
8.29
|
|
7
|
Trends in cancer risk among people with AIDS in the United States 1980-2002.
|
AIDS
|
2006
|
7.08
|
|
8
|
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
|
N Engl J Med
|
2007
|
7.05
|
|
9
|
EAU penile cancer guidelines 2009.
|
Eur Urol
|
2010
|
3.03
|
|
10
|
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease.
|
Int J Cancer
|
2005
|
2.79
|
|
11
|
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
|
J Clin Oncol
|
2005
|
2.66
|
|
12
|
Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases.
|
J Urol
|
2005
|
2.31
|
|
13
|
Penile cancer: epidemiology, pathogenesis and prevention.
|
World J Urol
|
2008
|
2.14
|
|
14
|
Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients.
|
Eur Urol
|
2008
|
2.02
|
|
15
|
Neoadjuvant chemotherapy in advanced penile carcinoma.
|
Eur Urol
|
2007
|
1.95
|
|
16
|
Penile carcinoma: a challenge for the developing world.
|
Lancet Oncol
|
2004
|
1.95
|
|
17
|
Incidence trends in primary malignant penile cancer.
|
Urol Oncol
|
2007
|
1.90
|
|
18
|
Systematic review of human papillomavirus prevalence in invasive penile cancer.
|
Cancer Causes Control
|
2008
|
1.89
|
|
19
|
Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results.
|
Eur Urol
|
2008
|
1.79
|
|
20
|
Human papillomavirus prevalence and type distribution in penile carcinoma.
|
J Clin Pathol
|
2009
|
1.77
|
|
21
|
Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience.
|
J Surg Oncol
|
2008
|
1.70
|
|
22
|
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.
|
Am J Pathol
|
2001
|
1.67
|
|
23
|
Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation.
|
J Urol
|
2007
|
1.65
|
|
24
|
Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resection.
|
Eur Urol
|
2010
|
1.55
|
|
25
|
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma.
|
J Clin Oncol
|
2007
|
1.53
|
|
26
|
Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.
|
J Clin Oncol
|
2010
|
1.49
|
|
27
|
Advanced penile carcinoma.
|
J Urol
|
2003
|
1.47
|
|
28
|
Edmonton symptom assessment scale: Italian validation in two palliative care settings.
|
Support Care Cancer
|
2005
|
1.43
|
|
29
|
Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study.
|
J Urol
|
1999
|
1.39
|
|
30
|
Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma.
|
J Urol
|
2007
|
1.35
|
|
31
|
Lymphadenectomy in the surgical management of penile cancer.
|
Eur Urol
|
2009
|
1.19
|
|
32
|
Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival.
|
J Urol
|
2007
|
1.15
|
|
33
|
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).
|
Ann Oncol
|
2008
|
1.14
|
|
34
|
Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas.
|
Cancer
|
1990
|
1.08
|
|
35
|
Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma.
|
J Natl Cancer Inst
|
1995
|
1.07
|
|
36
|
Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men.
|
Int J Cancer
|
2011
|
1.07
|
|
37
|
Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma.
|
BJU Int
|
2006
|
1.06
|
|
38
|
Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
|
Cancer
|
2001
|
1.05
|
|
39
|
Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis.
|
Acta Oncol
|
1988
|
1.05
|
|
40
|
Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.
|
J Urol
|
1995
|
1.04
|
|
41
|
Penile cancer: is there an epidemiological role for smoking and sexual behaviour?
|
Br Med J (Clin Res Ed)
|
1987
|
1.03
|
|
42
|
Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract.
|
J Urol
|
1991
|
1.02
|
|
43
|
Management of the lymph nodes in penile cancer.
|
Urology
|
2010
|
1.01
|
|
44
|
Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
|
J Urol
|
1998
|
1.01
|
|
45
|
cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study.
|
J Urol
|
1989
|
1.00
|
|
46
|
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
|
BJU Int
|
2012
|
1.00
|
|
47
|
Cisplatin and 5-fluorouracil in advanced cancer of the penis.
|
J Urol
|
1992
|
1.00
|
|
48
|
Chemotherapy for penile and urethral carcinoma.
|
Urol Clin North Am
|
2010
|
0.98
|
|
49
|
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study.
|
Eur Urol
|
2011
|
0.93
|
|
50
|
Dynamic sentinel node biopsy for inguinal lymph node staging in patients with penile cancer: a systematic review and cumulative analysis of the literature.
|
Ann Surg Oncol
|
2011
|
0.89
|
|
51
|
Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer.
|
Urology
|
2010
|
0.87
|
|
52
|
[The current state of the art of chemotherapy of penile cancer: results of a nationwide survey of German clinics].
|
Urologe A
|
2009
|
0.87
|
|
53
|
Human papillomavirus vaccination in males: the state of the science.
|
Curr Infect Dis Rep
|
2011
|
0.86
|
|
54
|
Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report.
|
Urol Int
|
2010
|
0.85
|
|
55
|
Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes.
|
World J Urol
|
2006
|
0.83
|
|
56
|
Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
|
Med Oncol
|
2013
|
0.83
|
|
57
|
Penile carcinogenesis in a low-incidence area: a clinicopathologic and molecular analysis of 115 invasive carcinomas with special emphasis on chronic inflammatory skin diseases.
|
Am J Surg Pathol
|
2011
|
0.83
|
|
58
|
Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.
|
J Urol
|
2010
|
0.80
|
|
59
|
Cisplatin and gemcitabine in the management of metastatic penile cancer.
|
Urol Oncol
|
2008
|
0.80
|
|
60
|
18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.80
|
|
61
|
Extended lymphadenectomy in penile cancer.
|
Can J Urol
|
2005
|
0.79
|
|
62
|
Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases.
|
Br J Urol
|
1983
|
0.79
|
|
63
|
Sentinel lymph node biopsy in penile cancer: evolution and insights.
|
Can J Urol
|
2005
|
0.76
|
|
64
|
Management of penile cancer.
|
J Surg Oncol
|
2008
|
0.76
|